PI3K-Akt signaling pathway was significantly enriched with extremely low p‐value, indicating that FD268 significantly altered PI3K-Akt pathway genes in human leukemia HL-60 cells which was consistent with the above western blot results. This evidence concerns the gene AKT1 and leukemia.